Motus GI Holdings, Inc. (MOTS): Price and Financial Metrics
MOTS Price/Volume Stats
| Current price | $0.45 | 52-week high | $3.18 |
| Prev. close | $0.45 | 52-week low | $0.43 |
| Day low | $0.45 | Volume | 24,100 |
| Day high | $0.48 | Avg. volume | 165,243 |
| 50-day MA | $0.53 | Dividend yield | N/A |
| 200-day MA | $0.77 | Market Cap | 2.15M |
MOTS Stock Price Chart Interactive Chart >
MOTS Stock Summary
- MOTS has a market capitalization of $2,799,390 -- more than approximately merely 1.17% of US stocks.
- MOTS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.66% of US stocks.
- MOTUS GI HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -311%, greater than the shareholder yield of just 2.15% of stocks in our set.
- Stocks that are quantitatively similar to MOTS, based on their financial statements, market capitalization, and price volatility, are PBYI, SCWX, VMEO, ATEN, and EXTR.
- Visit MOTS's SEC page to see the company's official filings. To visit the company's web site, go to www.motusgi.com.
MOTS Valuation Summary
- MOTS's EV/EBIT ratio is -0.3; this is 102.59% lower than that of the median Healthcare stock.
- Over the past 68 months, MOTS's price/sales ratio has gone NA NA.
Below are key valuation metrics over time for MOTS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MOTS | 2023-09-22 | 5.0 | -2.9 | -0.2 | -0.3 |
| MOTS | 2023-09-21 | 5.0 | -2.9 | -0.2 | -0.3 |
| MOTS | 2023-09-20 | 4.9 | -2.8 | -0.2 | -0.3 |
| MOTS | 2023-09-19 | 5.2 | -3.0 | -0.2 | -0.3 |
| MOTS | 2023-09-18 | 5.2 | -3.0 | -0.2 | -0.3 |
| MOTS | 2023-09-15 | 5.2 | -3.0 | -0.2 | -0.3 |
MOTS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MOTS has a Quality Grade of F, ranking ahead of 2.21% of graded US stocks.
- MOTS's asset turnover comes in at 0.008 -- ranking 170th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows MOTS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.008 | -1.391 | -8.260 |
| 2021-03-31 | 0.005 | -3.083 | -7.460 |
| 2020-12-31 | 0.004 | -4.061 | -8.708 |
| 2020-09-30 | 0.006 | 0.112 | -5.005 |
| 2020-06-30 | 0.005 | -0.321 | -3.413 |
| 2020-03-31 | 0.005 | -0.231 | -3.489 |
MOTS Price Target
For more insight on analysts targets of MOTS, see our MOTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $2.03 | Average Broker Recommendation | 1.25 (Strong Buy) |
Motus GI Holdings, Inc. (MOTS) Company Bio
Motus GI Holdings, Inc., a development stage company, engages in developing single-use medical device systems in the United States. It is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The company is based in Tirat Carmel, Israel.
Latest MOTS News From Around the Web
Below are the latest news stories about MOTUS GI HOLDINGS INC that investors may wish to consider to help them evaluate MOTS as an investment opportunity.
Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon– A special 510(k), according to FDA guidance, is usually reviewed within 30 days of receipt – – Pure-Vu Gen 4 platform opens up the Upper GI market, reduces the cost-of-goods by approximately 50% and minimizes the need for onsite support to new accounts – FORT LAUDERDALE, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that it has |
Motus GI Amends Royalty Agreement– Amended agreement eliminates approximately $1.0M in contingent royalty obligations from balance sheet – – Canceled royalty rights in exchange for common stock expected to improve Company’s stockholder equity, and simplify ongoing exploration of strategic and financing alternatives to maximize stockholder value – FORT LAUDERDALE, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endos |
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors-- David Hochman and Darren Sherman resign from Motus Board of Directors to focus on their executive obligations --FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors (the “Board”). Mr. Durbin has more than 25 years of executive leadership, finance and clini |
Motus Holdings Full Year 2023 Earnings: In Line With ExpectationsMotus Holdings ( JSE:MTH ) Full Year 2023 Results Key Financial Results Revenue: R106.3b (up 16% from FY 2022). Net... |
Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceFORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that Mark Pomeranz, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwright 25th Annual Global Investment ConferencePresentation Date:Monday, September 11, 2023 at 7:00 AM ETMeetings:Managemen |
MOTS Price Returns
| 1-mo | -10.18% |
| 3-mo | N/A |
| 6-mo | -47.98% |
| 1-year | -81.63% |
| 3-year | -97.67% |
| 5-year | -99.53% |
| YTD | -46.43% |
| 2022 | -91.01% |
| 2021 | -50.74% |
| 2020 | -58.60% |
| 2019 | -26.37% |
| 2018 | N/A |
Continue Researching MOTS
Want to see what other sources are saying about Motus GI Holdings Inc's financials and stock price? Try the links below:Motus GI Holdings Inc (MOTS) Stock Price | Nasdaq
Motus GI Holdings Inc (MOTS) Stock Quote, History and News - Yahoo Finance
Motus GI Holdings Inc (MOTS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...